SYMPOSIUM ON DRUG INFORMATION — How Can it Best Be Provided? Newsletter Article 12 February 2013 Pages: 3 - 4
CHANGING ASTHMATICS FROM ORAL STEROIDS TO AEROSOL TREATMENT Newsletter Article 12 February 2013 Pages: 4 - 4
POST-MARKETING SURVEILLANCE OF ADVERSE DRUG REACTIONS Newsletter Article 12 February 2013 Pages: 4 - 5
RENAL CALCULUS ASSOCIATED WITH ACETAZOLAMIDE THERAPY Newsletter Article 12 February 2013 Pages: 5 - 5
IF METHYLDOPA CAUSES RENAL STONES, IT DOES NOT HAPPEN OFTEN Newsletter Article 12 February 2013 Pages: 5 - 5
FIXED DRUG ERUPTION WITH METRONIDAZOLE — First Report Newsletter Article 12 February 2013 Pages: 6 - 6
PHENYLEPHRINE EYE DROPS MAY CAUSE HYPERTENSION IN INFANTS Newsletter Article 12 February 2013 Pages: 7 - 7
NAFTIDROFURYL LOOKS PROMISING IN MÉNIÈRE’S DISORDER Newsletter Article 12 February 2013 Pages: 8 - 8
MASSIVE ORAL DOSES OF MEDROXYPROGESTERONE ACETATE IN ONCOLOGY Newsletter Article 12 February 2013 Pages: 9 - 9
MEBENDAZOLE: AS CHEMOTHERAPY FOR HEPATIC HYDATID CYSTS Newsletter Article 12 February 2013 Pages: 11 - 11
FRUSEMIDE OR HYDROCHLOROTHIAZIDE FOR MILD HYPERTENSION? Newsletter Article 12 February 2013 Pages: 12 - 12
LENPERONE: Antipsychotic Effects, Side-Effects and Dosage Newsletter Article 12 February 2013 Pages: 13 - 13
MYCOPHENOLIC ACID: An Encouraging Alternative for Psoriasis Newsletter Article 12 February 2013 Pages: 13 - 13
CAUTION IS ADVISED IN USING IV FRUSEMIDE AFTER CHLORAL HYDRATE Newsletter Article 12 February 2013 Pages: 14 - 15
ALCLOFENAC, NON-STEROIDAL ANTI-INFLAMMATORY AGENT: A REVIEW Newsletter Article 12 February 2013 Pages: 17 - 18